<DOC>
	<DOCNO>NCT01930552</DOCNO>
	<brief_summary>Primary Objective : To assess safety pharmacokinetics preliminarily dose intravenous ( IV ) aflibercept use western study combination FOLFIRI ( Irinotecan , 5-Fluorouracil , Leucovorin ) give intravenously every 2 week Chinese patient solid tumor . Secondary Objectives : - To make preliminary assessment antitumor effect combination FOLFIRI plus aflibercept patient measurable disease ( RECIST 1.1 ) . - To evaluate immunogenicity IV aflibercept .</brief_summary>
	<brief_title>A Phase I Study Aflibercept Plus FOLFIRI ( Irinotecan , 5-Fluorouracil , Leucovorin ) Chinese Patients With Advanced Solid Malignancies</brief_title>
	<detailed_description>Total duration study per patient range 17 29 week . This trial conduct China , INN designation study molecule `` aflibercept '' term therefore use throughout synopsis . In US , US proper name `` ziv-aflibercept '' .</detailed_description>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Irinotecan</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>Inclusion criterion : Histologically cytologically confirm solid malignancy metastatic unresectable FOLFIRI ( Irinotecan , 5Fluorouracil , Leucovorin ) treatment appropriate Exclusion criterion : Treatment chemotherapy , hormonal therapy , radiotherapy , surgery , investigational agent within 28 day Eastern Cooperative Oncology Group ( ECOG ) &gt; 1 Need major surgical procedure radiation therapy study Diagnosis squamouscell lung cancer Cumulative radiation therapy &gt; 25 % total bone marrow History brain metastasis Inadequate organ bone marrow function Uncontrolled hypertension Evidence clinically significant bleed diathesis underlie coagulopathy Prior FOLFIRI treatment appropriate safety reason Patients know Gilbert 's syndrome The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>